Overview Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis Status: Completed Trial end date: 2015-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of itraconazole monotherapy in patients with ABPA. Phase: Phase 2/Phase 3 Details Lead Sponsor: Postgraduate Institute of Medical Education and ResearchTreatments: FluticasoneFormoterol FumarateGlucocorticoidsHydroxyitraconazoleItraconazoleMethylprednisoloneMethylprednisolone acetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate